The combined effects of tamoxifen or proglumide with 5-fluorouracil on the growth of murine transplantable Colon 38 cancer

GI Cancer

Volumn 3, Issue 5, 2001, Pages 383-394

  Meleń Mucha, Gabriela ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Colon 38 cancer; Pentagastrin; Proglumide; Tamoxifen

Indexed keywords

ESTROGEN; FLUOROURACIL; GASTRIN; PENTAGASTRIN; PROGLUMIDE; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL NUCLEUS; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0035685086     PISSN: 10649700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. New possibilities in chemotherapy for colorectal cancer
2. Gastrin stimulates growth of colon cancer
3. Stimulating effect of pentagastrin on cancer cell proliferation kinetics in chemically induced colon cancer in rats
4. Omeprazol - Induced hipergastrinemia does not influence growth of colon carcinoma
5. Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice
6. Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors
7. Reproductive factors related to the risk of colorectal cancer by subsite: A case-control anaysis
8. General epidemiologic considerations in aetiology of colorectal cancer
9. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis
10. Tamoxifen and risk of large bowel cancer in women with breast cancer
11. Reproduction, endogenous and exogenous sex hormones, and colon cancer: A review and hypothesis
12. Methylation of the estrogen receptor CpG island links aging and neoplasia in human colon
13. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor I, growth hormone and sex hormone binding globulin serum levels
14. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro
15. The tamoxifen dilemma
16. Effect of tamoxifen on 1,2-dimethylhydrazine-HCl-induced colon carcinogenesis in rats
17. Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro
18. Recent advances in understanding the molecular mechanisms of tamoxifen action
19. Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: A new reagent for detection of DNA replication
20. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation
21. The effects of pentagastrin, proglumide, tamoxifen and their joint treatment with 5-fluorouracil on the proliferation, apoptosis, necrosis and tumor mass of Colon 38 tumors in mice
22. Effects of gastrin, proglumide, loxiglumide and L-356,260 on growth of human colon carcinoma cells
23. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells
24. Synergistic effect of paclitaxel and 4-hydroxytamoxifen on estrogen receptor-negative colon cancer and lung cancer cell lines
25. Effects of somatostatin analogs octreotide and lanreotide on the proliferation and apoptosis in Colon 38 tumor: Interaction with 5-fluorouracil
26. 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice
27. The relationships between p53-dependent apoptosis, inhibition of proliferation and 5-fluorouracil-induced histopathology in murine intestinal epithelia
28. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas
29. S-phase accumulation precedes apoptosis induced by preoperative treatment with 5-fluorouracil in human colorectal carcinoma cells